Target intelligence / Profile preview

Pseudogene similar to part of adenosine deaminase, tRNA-specific 2, TAD2 homolog (null)

Target: null
Molecular classification: Pseudogene

Overview

Pseudogene similar to part of adenosine deaminase, tRNA-specific 2, TAD2 homolog (ENSG00000243621) is a non-functional segment of DNA in the human genome that shares sequence similarity with the yeast gene TAD2, which encodes a tRNA-specific adenosine deaminase. As a pseudogene, it lacks the necessary regulatory or coding regions to produce a functional protein. Most pseudogenes, including this one, are not directly involved in physiological functions, but some may play subtle regulatory roles in gene expression, such as acting as decoys for microRNAs or influencing mRNA stability. This pseudogene is not considered a therapeutic target and has no known involvement in disease or drug interaction[1][3][4].

Other names: ADAT2 pseudogeneTAD2 homolog pseudogeneENSG00000243621pseudogene similar to part of adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. Cerevisiae)

Mechanism of action

None (no drugs or therapies are known to act on this pseudogene[1].)

Biological functions

Pseudogenes do not have canonical protein-coding functions, but they may have subtle regulatory effects such as acting as microRNA decoys or affecting gene expression via antisense transcripts or siRNAs, as discussed in recent literature[3][4].

Disease associations

Some pseudogenes have been implicated in regulatory roles in cancer or other diseases, but there is no evidence specifically linking ENSG00000243621 to any disease[3][4].

Beyond the preview

Go deeper on Pseudogene similar to part of adenosine deaminase, tRNA-specific 2, TAD2 homolog (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudogene similar to part of adenosine deaminase, tRNA-specific 2, TAD2 homolog (null).

Explore the full profile